Acetyl-Carnitine and Reduced Neuropathic Pain

Research synthesisLow evidenceModerate effect3 studies · 2 beneficial · 1 neutral · 0 harmful

Across 3 studies, 2 reported beneficial moderate-sized effects on reducing neuropathic pain, while 1 systematic review found no effect. Effects typically observed at around 8 weeks (median 56 days). Studies involved adults with chronic neuropathic pain or peripheral neuropathies.

Studied populations: adults with neuropathic pain conditions (chronic neuropathic pain, acute low back trauma, peripheral neuropathies)

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. One study was a systematic review that found no effect, and one study focused on acute low back pain rather than classic neuropathic pain. Dosing was not reported consistently across studies.

Generated May 13, 2026

Time to effect

Median: 8 weeks · IQR 8 weeks–8 weeks · Range 8 weeks–8 weeks — Reported in 1 of 3 studies

Safety in these studies

Overall tolerabilityIncreased risk
Acetyl-l-carnitine was found to be likely ineffective or harmful.
from: The role of diet and non-pharmacologic supplements in the treatment of chronic neuropathic

3 of 3 papers

The role of diet and non-pharmacologic supplements in the treatment of chronic neuropathic pain: A systematic review.
- 2023-08-31
- Systematic Review
- Pain practice : the official journal of World Institute of Pain 24(1)
- - Jennifer K Frediani
  - Asim A Lal
  - Esther Kim
  - Sharon L Leslie
  - David W Boorman
  - Vinita Singh
- PubMed: 37654090
- DOI: 10.1111/papr.13291
5 Insights on
- Reduced Neuropathic Pain
- High evidence
- Clinical
Magnesium (1) and St. John's wort (1) were studied for other or mixed neuropathologies.
Effect
Neutral
Effect size
Small
Significant
No
Unlocking Relief: Investigating the Impact of a Fixed Combination of Acetyl-L-Carnitine and Palmitoylethanolamide on Traumatic Acute Low Back Pain.
- 2025-08
- Observational · n = 48
- European journal of neurology 32(8)
- - Mattia Cominacini
  - Maria Teresa Valenti
  - Michele Braggio
  - Alberto Caramori
  - Ermes Vedovi
  - Luca Dalle Carbonare
- PubMed: 40853095
- DOI: 10.1111/ene.70334
3 Insights on
- Reduced Neuropathic Pain
- Moderate evidence
- Clinical
significant reductions in NPS and VAS scores
Effect
Beneficial
Effect size
Moderate
Significant
Yes
Acetyl-L-Carnitine in the Treatment of Peripheral Neuropathies: A Narrative Review.
- 2026-03-13
- Review
- Pain and therapy 15(3)
- - Diego Maria Michele Fornasari
- PubMed: 41824218
- DOI: 10.1007/s40122-026-00826-x
1 Insight on
- Reduced Neuropathic Pain
- Low evidence
- Clinical
its long-term neurotrophic and analgesic activity has been confirmed in animal models of chronic inflammatory and neuropathic pain and in clinical studies in patients with peripheral neuropathies.
Effect
Beneficial
Effect size
Moderate
Significant
Yes

Acetyl-Carnitine and Reduced Neuropathic Pain

The role of diet and non-pharmacologic supplements in the treatment of chronic neuropathic pain: A systematic review.

Unlocking Relief: Investigating the Impact of a Fixed Combination of Acetyl-L-Carnitine and Palmitoylethanolamide on Traumatic Acute Low Back Pain.

Acetyl-L-Carnitine in the Treatment of Peripheral Neuropathies: A Narrative Review.